How to Get Alprostadil (Caverject/MUSE) in Washington State

Prescription access and medication affordability image for How to Get Alprostadil (Caverject/MUSE) in Washington State

At a glance

  • Drug / alprostadil (prostaglandin E1), brand names Caverject and MUSE
  • Dose forms / intracavernosal injection (2.5 to 40 mcg) or urethral suppository (125, 1 to 000 mcg)
  • Prescribers / MD, DO, NP, or PA licensed in Washington State
  • Telehealth Rx / permitted under Washington telehealth law
  • Compounding / 503A pharmacies in WA may compound alprostadil
  • Washington Medicaid / covered for refractory ED with prior authorization
  • Typical onset / 5 to 20 minutes after administration
  • Key trial / Linet 1996 (NEJM): 94.8% of injections produced erections sufficient for intercourse
  • Manufacturer / Pfizer (Caverject Impulse) and generics
  • Schedule / not a controlled substance; prescription required

What Is Alprostadil and How Does It Work?

Alprostadil is a synthetic prostaglandin E1 that relaxes smooth muscle in the corpus cavernosum, dilates cavernosal arteries, and produces an erection within 5 to 20 minutes of administration. It works regardless of psychogenic, neurogenic, or vasculogenic cause, which makes it especially useful for men who have not responded to phosphodiesterase-5 (PDE5) inhibitors such as sildenafil or tadalafil. The drug is FDA-approved in two delivery forms: Caverject (and Caverject Impulse) as an intracavernosal injection, and MUSE as a urethral suppository pellet. FDA approval data for both products is indexed at the accessdata portal. [1]

The landmark Linet et al. trial published in the New England Journal of Medicine (1996, N=296) found that 94.8% of alprostadil intracavernosal injections produced erections sufficient for intercourse, compared with 10.9% with placebo (P<0.001). [2] That trial also established the dose range that remains standard today: 2.5 to 40 mcg per injection, titrated in-office before home use.

Because alprostadil produces a pharmacologic erection independent of sexual stimulation, patient training is a clinical requirement before dispensing. Washington urology practices and telehealth platforms that prescribe the injection form must document a supervised first-dose titration, either in-office or via an on-camera procedure session.

Washington State Telehealth Rules for Alprostadil

Washington allows full telehealth prescribing of alprostadil. The state follows its Telemedicine Collaborative guidelines, which permit a valid prescriber-patient relationship to be established via synchronous audio-video. No in-person visit is legally mandated before receiving an alprostadil prescription in Washington, though most clinicians require at least one video consultation that includes a structured erectile-dysfunction history and a review of cardiovascular risk. Washington's telemedicine framework is maintained by the Department of Health under RCW 70.41.

A telehealth prescriber in Washington must hold an active Washington State license (MD, DO, PA, or ARNP). Out-of-state practitioners cannot prescribe to Washington patients unless they hold a Washington license or a qualifying interstate compact credential. The Federation of State Medical Boards tracks compact participation. [3]

Telehealth platforms that prescribe alprostadil in Washington typically complete the following steps in seven to fourteen business days:

  1. Intake questionnaire covering ED history, cardiovascular status, and current medications
  2. Synchronous video visit with a licensed Washington prescriber
  3. Lab review (see the labs section below)
  4. Electronic prescription sent to a Washington-licensed pharmacy or compounding pharmacy
  5. Shipment to the patient's Washington address

The American Urological Association's 2018 Erectile Dysfunction Guideline states: "Intracavernosal injection therapy is recommended for men with ED who do not respond to or cannot take PDE5 inhibitors." [4] That recommendation applies without restriction to telehealth-initiated care when appropriate training is documented.

Who Can Prescribe Alprostadil in Washington?

Four prescriber categories can legally write an alprostadil prescription in Washington State.

MDs and DOs have unrestricted prescribing authority. Urologists, men's health specialists, and primary care physicians routinely prescribe both Caverject and MUSE. Washington Medical Commission licensing rules are available at the DOH portal. [5]

Physician Assistants (PAs) in Washington hold prescriptive authority and may prescribe alprostadil within their scope of practice, generally under a practice agreement with a supervising physician. Washington's PA prescribing statute is under RCW 18.57A.

Advanced Registered Nurse Practitioners (ARNPs) have full independent prescribing authority in Washington. Washington is a full-practice-authority state, so ARNPs do not require physician supervision to prescribe alprostadil. The AANP confirms Washington's full-practice-authority status. [6]

Naturopathic Physicians (NDs) hold limited prescribing rights in Washington but are generally not authorized to prescribe prostaglandins like alprostadil. Patients consulting an ND for ED should request a referral to an MD, DO, PA, or ARNP.

Labs Required Before Starting Alprostadil in Washington

Most Washington prescribers order baseline labs before writing an alprostadil prescription, though no federal or state regulation mandates a specific panel. The clinical rationale is identifying underlying causes of erectile dysfunction and ruling out contraindications. A standard pre-treatment panel typically includes:

Telehealth platforms in Washington can direct patients to Quest Diagnostics, LabCorp, or any Washington-licensed draw site. Results are typically reviewed within 48 to 72 hours before the prescriber finalizes the alprostadil order. Quest's patient service center finder lists Washington locations.

Pharmacies Dispensing Alprostadil in Washington

Brand Name (Caverject / MUSE)

Both Caverject Impulse (Pfizer) and MUSE (Meda Pharmaceuticals) are commercially available and can be filled at any Washington retail pharmacy with a valid prescription. Major chains including Walgreens, CVS (limited Washington presence), Bartell Drugs, and Rite Aid stock or can special-order Caverject. MUSE is less commonly stocked and may require a 24, 72-hour order. Average retail cash prices without insurance run $90, $180 per Caverject Impulse dual-chamber syringe and $250, $350 for a six-pack of MUSE 500 mcg suppositories. GoodRx and manufacturer copay cards can reduce these costs materially. Pfizer's patient assistance information is available at the manufacturer's site, referenced in the FDA label. [1]

503A Compounding Pharmacies

Washington-licensed 503A compounding pharmacies can legally prepare patient-specific alprostadil formulations when a valid prescription is presented. Compounded alprostadil is typically prepared as a multi-drug penile injection (TRIMIX or BIMIX) that combines alprostadil with papaverine and/or phentolamine to increase efficacy and reduce per-dose alprostadil cost. The FDA's compounding guidance distinguishes 503A patient-specific compounding from 503B outsourcing facilities. [10]

503A pharmacies in Washington must be licensed by the Washington State Pharmacy Quality Assurance Commission. The Commission's license verification database is public. Patients using a telehealth prescriber can receive a compounded alprostadil formulation shipped directly to their Washington address, provided the compounding pharmacy holds an active Washington dispensing license.

Important: The FDA does not permit commercial-scale compounding of alprostadil in the absence of a patient-specific prescription at a 503A pharmacy. Bulk-distributed compounded alprostadil from unlicensed facilities does not meet Washington's dispensing standards. [11]

Washington Medicaid Coverage and Prior Authorization

Washington Apple Health (Medicaid) covers alprostadil for refractory erectile dysfunction, defined as ED that has not responded to at least two trials of oral PDE5 inhibitors at adequate doses. Coverage requires prior authorization (PA). Prescribers must submit documentation that includes:

  1. Diagnosis of erectile dysfunction (ICD-10: N52.9 or a specific etiologic code such as N52.01 for vasculogenic ED)
  2. Evidence of PDE5 inhibitor failure (two agents at recommended doses for at least four weeks each)
  3. Clinical notes supporting medical necessity
  4. Prescriber's Washington NPI and license number

The Washington Health Care Authority (HCA) administers Apple Health pharmacy benefits through managed care organizations including Molina Healthcare of Washington, Community Health Plan of Washington, and Coordinated Care. The HCA's preferred drug list and PA criteria are published at. [12]

PA approval typically takes 3, 5 business days from submission. If denied, Washington Medicaid allows an expedited appeals process within 72 hours for urgent clinical cases. Some Apple Health managed care plans add a step requiring the prescriber to document why the patient cannot use a generic sildenafil or tadalafil formulation before approving the injectable.

Commercial insurance coverage varies by plan. Most Washington Blue Cross Blue Shield, Premera, and Regence plans require a PA for alprostadil similar to Medicaid. Patients should verify their specific formulary tier before filling. The CMS formulary guidance relevant to Washington plans is at. [13]

Transferring an Existing Alprostadil Prescription to Washington

Patients who relocate to Washington with an existing alprostadil prescription from another state face a straightforward but multi-step process.

Washington pharmacies can accept an out-of-state prescription for a non-controlled substance like alprostadil if the prescription was written by a licensed prescriber in the originating state and has remaining refills. However, many pharmacies request verification with the original prescriber, which can add 24 to 48 hours. The Washington State Pharmacy Quality Assurance Commission's rules on out-of-state prescriptions are under WAC 246-945. [14]

The cleaner option for new Washington residents is to schedule a telehealth visit with a Washington-licensed prescriber who can review the existing treatment plan and issue a new Washington prescription. This also gives the prescriber an opportunity to reassess current dose, technique, and any adverse effects. Telehealth platforms serving Washington can complete this in three to five business days.

Patients using a 503A compounded formulation from an out-of-state compounding pharmacy should be aware that the compounding pharmacy must hold a Washington dispensing license to ship into the state. If it does not, a Washington-licensed compounding pharmacy will need to receive a new prescription from a Washington prescriber. [15]

Dosing and Administration: What Washington Patients Should Expect

Alprostadil intracavernosal injection (Caverject) is initiated at 2.5 mcg for neurogenic erectile dysfunction or 5 mcg for vasculogenic or mixed-cause ED, then titrated upward in 5 to 10 mcg increments at the prescriber's direction until an erection of 60 minutes or less is produced. The FDA label recommends that the first dose be given under medical supervision. [2] Home use begins only after the patient demonstrates correct injection technique.

MUSE suppositories begin at 125 to 250 mcg and are titrated to 500 or 1 to 000 mcg. MUSE requires urethral insertion using the applicator provided and produces erections in roughly 30 to 40% of users, a lower response rate than intracavernosal injection. A key MUSE trial (N=1,511) published in the New England Journal of Medicine found that 64.9% of patients in the active group had at least one successful intercourse attempt vs. 18.6% in the placebo group. [16]

The maximum recommended frequency for Caverject is three times per week, with at least 24 hours between uses. For MUSE, the maximum is two doses per 24 hours. Patients experiencing a prolonged erection lasting more than four hours (priapism) should seek emergency care immediately. The AUA's priapism guideline is at. [17]

Adverse Effects and Contraindications Washington Prescribers Assess

Penile pain is the most common adverse effect with Caverject, reported in approximately 37% of patients in the Linet trial. [2] Other effects include prolonged erection (priapism, 1 to 4%), penile fibrosis with long-term use (<3%), and hypotension, particularly with MUSE. Published incidence data for alprostadil adverse effects are summarized in the prescribing information indexed at the FDA. [1]

Contraindications include:

  • Known hypersensitivity to alprostadil
  • Conditions predisposing to priapism (sickle cell anemia, multiple myeloma, leukemia)
  • Penile implant in place
  • Sexual activity contraindicated due to cardiovascular status (New York Heart Association Class IV or unstable angina)

Washington prescribers evaluating cardiovascular risk often reference the Princeton Consensus (third conference recommendations), which stratifies men with ED by cardiac risk before any erectogenic therapy. The third Princeton Consensus is published in the American Journal of Cardiology. [18] Men in the high-risk cardiovascular category require cardiology clearance before alprostadil can be prescribed, regardless of whether the consultation is telehealth or in-person.

Cost Estimates and Patient Assistance in Washington

Cash-pay pricing for brand Caverject Impulse 10 mcg at Washington pharmacies typically runs $130, $180 per single-dose kit. MUSE 500 mcg suppositories average $55, $65 per suppository without insurance. Compounded intracavernosal formulations (TRIMIX with alprostadil) from Washington 503A pharmacies average $60, $120 per multi-dose vial containing 10, 20 doses, making them substantially more affordable than brand-name Caverject at the per-dose level.

Pfizer offers a Caverject copay assistance card that reduces out-of-pocket cost to as low as $0 for commercially insured patients and $99 for uninsured patients per fill. Program details are referenced in the product labeling portal. [1] NeedyMeds and RxAssist also maintain manufacturer assistance program listings for patients below income thresholds. [RxAssist is listed at rxassist.org and NeedyMeds at needymeds.org, both of which cross-reference manufacturer programs.]

Washington's Basic Health program and state-funded community health centers (Neighborcare Health, Sea Mar Community Health Centers, and others) may provide alprostadil at reduced cost for uninsured patients who qualify for sliding-scale care. The HRSA health center finder lists Washington locations. [19]

Frequently asked questions

How do I get an alprostadil (Caverject/MUSE) prescription in Washington?
Schedule a telehealth visit or in-person appointment with a Washington-licensed MD, DO, NP, or PA. The prescriber will review your ED history, current medications, cardiovascular status, and baseline labs, then write an electronic prescription if you qualify. Most telehealth platforms complete this in seven to fourteen business days from intake to prescription delivery.
What labs are needed before alprostadil (Caverject/MUSE) in Washington?
Standard pre-treatment labs include total and free testosterone, fasting glucose, HbA1c, lipid panel, complete blood count, and basic metabolic panel. Some prescribers also order PSA if concurrent testosterone therapy is being considered. Labs can be drawn at any Washington LabCorp or Quest Diagnostics location.
Are there telehealth providers in Washington prescribing alprostadil (Caverject/MUSE)?
Yes. Washington law permits synchronous audio-video telehealth visits to establish a prescriber-patient relationship for alprostadil. The prescriber must hold an active Washington State license. Platforms operating in Washington include men's health telehealth services and urology-affiliated virtual clinics.
How long until I receive alprostadil (Caverject/MUSE) in Washington?
From initial telehealth intake to prescription in hand, the typical timeline is seven to fourteen business days. Lab processing adds two to five business days. Once the prescription is issued, retail pharmacy fulfillment is same-day to three days, and compounding pharmacy shipment is three to seven business days.
Can I transfer an alprostadil (Caverject/MUSE) prescription to Washington?
Yes. Washington pharmacies can accept a valid out-of-state non-controlled substance prescription with remaining refills. Verification with the original prescriber may add 24 to 48 hours. The cleaner option is a new telehealth visit with a Washington-licensed prescriber who can issue a Washington prescription directly.
Are 503A pharmacies in Washington licensed to ship alprostadil?
Yes. Washington-licensed 503A compounding pharmacies can compound and dispense alprostadil (and multi-drug formulations like TRIMIX) to Washington patients with a valid patient-specific prescription. The pharmacy must be licensed by the Washington State Pharmacy Quality Assurance Commission. An out-of-state 503A pharmacy must also hold a Washington dispensing license to ship into the state.
Who can prescribe alprostadil (Caverject/MUSE) in Washington: MD vs NP vs PA?
MDs and DOs have unrestricted prescribing authority. Advanced Registered Nurse Practitioners (ARNPs) have full independent prescribing authority in Washington, a full-practice-authority state. Physician Assistants (PAs) may prescribe alprostadil within a practice agreement. Naturopathic physicians are generally not authorized to prescribe prostaglandins in Washington.
What documentation does prior authorization require for alprostadil in Washington?
Washington Apple Health (Medicaid) prior authorization for alprostadil requires: an ICD-10 erectile dysfunction diagnosis, documentation of failure of at least two PDE5 inhibitors at adequate doses for at least four weeks each, clinical notes supporting medical necessity, and the prescriber's Washington NPI and license number. PA approval typically takes three to five business days.
Is alprostadil a controlled substance in Washington?
No. Alprostadil is not a scheduled controlled substance under federal or Washington State law. It requires a prescription but has no DEA scheduling, no quantity limits tied to controlled-substance rules, and no requirement for in-person prescribing under federal controlled-substance regulations.
What is the difference between Caverject and MUSE for Washington patients?
Caverject is an intracavernosal injection delivering alprostadil directly into penile tissue, producing erections in 85 to 95 percent of men at adequate doses. MUSE is a urethral suppository that is less invasive but has a lower response rate, with roughly 65 percent of patients achieving one successful intercourse attempt in the key trial. Washington prescribers and patients choose based on preference, tolerability, and response.
Can I use alprostadil if I take blood pressure medications?
Alprostadil can cause local and systemic hypotension, particularly the MUSE form. Washington prescribers review all antihypertensive medications before prescribing. Concurrent use with antihypertensives requires careful dose titration and blood pressure monitoring. This is not an absolute contraindication, but it does require clinical review and potentially a lower starting dose.

References

  1. U.S. Food and Drug Administration. Caverject and MUSE prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
  2. Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996;334(14):873-877. https://pubmed.ncbi.nlm.nih.gov/8638121/
  3. Federation of State Medical Boards. Interstate Medical Licensure Compact. https://www.fsmb.org/advocacy/interstate-medical-licensure-compact/
  4. Burnett AL, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746670/
  5. Washington State Department of Health. Physician licensing. https://www.doh.wa.gov/LicensesPermitsandCertificates/ProfessionsNewReneworUpdate/Physician
  6. American Association of Nurse Practitioners. State practice environment. https://www.aanp.org/advocacy/state/state-practice-environment
  7. Rastrelli G, et al. Testosterone and sexual function in men. Maturitas. 2018;112:46-52. https://pubmed.ncbi.nlm.nih.gov/31630951/
  8. Bhasin S, et al. Testosterone therapy in men with androgen deficiency syndromes. J Clin Endocrinol Metab. 2010;95(6):2536-2559. https://pubmed.ncbi.nlm.nih.gov/20525905/
  9. Selvin E, et al. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120(2):151-157. https://pubmed.ncbi.nlm.nih.gov/16422843/
  10. U.S. Food and Drug Administration. Compounding laws and policies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  11. U.S. Food and Drug Administration. 503A vs 503B compounding framework. https://www.fda.gov/drugs/human-drug-compounding/503a-and-503b-compounders
  12. Washington Health Care Authority. Preferred drug list and prior authorization criteria. https://www.hca.wa.gov/billers-providers-partners/programs-and-services/preferred-drug-list-pdl
  13. Centers for Medicare and Medicaid Services. Prescription drug coverage general information. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovgenin
  14. Washington State Legislature. WAC 246-945 Pharmacy quality assurance commission rules. https://apps.leg.wa.gov/wac/default.aspx?cite=246-945
  15. National Association of Boards of Pharmacy. Interstate pharmacy dispensing. https://nabp.pharmacy/programs/inspections/
  16. Padma-Nathan H, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med. 1997;336(1):1-7. https://pubmed.ncbi.nlm.nih.gov/9054374/
  17. American Urological Association. Priapism guideline. https://www.auanet.org/guidelines-and-quality/guidelines/priapism-guideline
  18. Nehra A, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/22698428/
  19. Health Resources and Services Administration. Find a health center. https://findahealthcenter.hrsa.gov/